New combo before liver surgery shows promise against tough tumors
Disease control
Recruiting now
This study tests whether giving a combination of two drugs (apatinib and camrelizumab) along with a procedure called TACE before liver surgery can shrink tumors and lower the chance of cancer coming back. It includes 27 adults with a specific type of liver cancer that can be remo…
Phase: PHASE2 • Sponsor: Wei Zhang • Aim: Disease control
Last updated May 15, 2026 11:57 UTC